Robert D Shamburek Selected Research

Robert D Shamburek Research Topics

Disease

8	Atherosclerosis 03/2016 - 05/2004
6	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 01/2019 - 06/2006
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2011
3	Insulin Resistance 01/2022 - 09/2014
3	Lipodystrophy 02/2021 - 09/2014
3	Coronary Disease (Coronary Heart Disease) 01/2016 - 02/2005
2	Hypertriglyceridemia 02/2021 - 01/2017
2	Obesity 01/2020 - 09/2014
2	Anemia 01/2017 - 03/2016
1	Congenital Bone Marrow Failure Syndromes 01/2022
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 01/2022
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 02/2021
1	Kidney Diseases (Kidney Disease) 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Disease Progression 01/2019
1	Acute Coronary Syndrome 07/2018
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2017
1	Pancreatitis 01/2017
1	Corneal Opacity 03/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015
1	Psoriatic Arthritis 01/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2015
1	Dyslipidemias (Dyslipidemia) 01/2015
1	Autoimmune Lymphoproliferative Syndrome 01/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2014
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 04/2011
1	Inflammation (Inflammations) 02/2008
1	Hyperlipidemias (Hyperlipidemia) 02/2005
1	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 12/2002

Drug/Important Bio-Agent (IBA)

10	Lipoproteins (Lipoprotein)IBA 01/2022 - 12/2002
7	LipidsIBA 01/2022 - 05/2004
7	HDL CholesterolIBA 03/2016 - 05/2004
4	Triglycerides (Triacylglycerol)IBA 02/2021 - 09/2014
3	LeptinIBA 02/2021 - 09/2014
3	metreleptinIBA 02/2021 - 09/2014
3	HDL LipoproteinsIBA 08/2019 - 06/2006
3	CholesterolIBA 01/2019 - 11/2006
3	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 01/2017 - 01/2016
3	LDL CholesterolIBA 01/2015 - 02/2005
3	oxidized low density lipoproteinIBA 01/2015 - 02/2005
3	Apolipoproteins B (ApoB)IBA 04/2009 - 10/2004
3	Apolipoproteins E (ApoE)IBA 10/2004 - 12/2002
2	Apolipoproteins C (ApoC)IBA 02/2021 - 01/2017
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 02/2021 - 08/2019
2	Lipoprotein-XIBA 01/2019 - 06/2006
2	SterolsIBA 01/2007 - 05/2004
1	Branched-Chain Amino AcidsIBA 01/2022
1	AndrogensIBA 01/2022
1	Apolipoproteins AIBA 02/2021
1	Apolipoprotein C-IIIIBA 02/2021
1	Angiopoietin-Like Protein 8IBA 02/2021
1	Investigational DrugsIBA 01/2020
1	VitaminsIBA 01/2020
1	Vitamin E FDA LinkGeneric 01/2020
1	Tocopherols (Tocopherol)IBA 01/2020
1	ChylomicronsIBA 08/2019
1	Insulin (Novolin)FDA Link 08/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Filipin (Filipin III)IBA 01/2019
1	Apolipoprotein C-II (ApoC2)IBA 01/2017
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2017
1	Lipoprotein(a)IBA 03/2016
1	EnzymesIBA 03/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2015
1	MicroRNAs (MicroRNA)IBA 04/2011
1	Scavenger Receptors (Scavenger Receptor)IBA 04/2011
1	Pharmaceutical PreparationsIBA 04/2009
1	Type I Tumor Necrosis Factor ReceptorsIBA 02/2008
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2007
1	Peptides (Polypeptides)IBA 03/2007
1	Ezetimibe (Zetia)FDA Link 01/2007
1	butyl phosphorotrithioate (DEF)IBA 06/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 06/2006
1	Phytosterols (Plant Sterols)IBA 02/2005
1	policosanolIBA 02/2005
1	LigandsIBA 10/2004
1	Lipase (Acid Lipase)FDA Link 10/2004
1	LDL Receptors (LDL Receptor)IBA 05/2004

Therapy/Procedure

4	Therapeutics 01/2022 - 02/2005
1	Enzyme Replacement Therapy 07/2018
1	Liver Transplantation 03/2016